- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02842398
Independent Walking Speed and Crossing a City Street
May 17, 2018 updated by: Blythedale Children's Hospital
The purpose of this study is to determine if selected sequence training using the Balance Master, added to established physical therapy treatment programs, will increase gait velocity of ambulatory children receiving inpatient or outpatient rehabilitation in relation to their ability to cross an intersection within the confines of community traffic signal (>120 cm/sec).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The ability to adequately perform functional tasks at a level that allows independent community living is key to measuring the success of any physical therapy program.
The essential tasks needed to allow independent community living have been well documented in the elderly population.
However, these tasks have not been delineated in the pediatric population.
The investigators aim to determine if selected sequence training using the Balance Master, added to established physical therapy treatment programs, will increase gait velocity of ambulatory children receiving in-or outpatient rehabilitation in relation to their ability to cross an intersection within the confines of community traffic signal (>120 cm/sec).
One essential task that is necessary in the urban environment is to have the ability to cross a street within the time constraint of a traffic signal.
Walking speed becomes increasingly important for those living in urban settings, as the ability to cross the street safely is fundamental for achieving independence.
One of the major criticisms of clinic/lab-based measures of gait speed is that relative performance may not be representative of independence within the community.
Participants aged 5 to 21 years, will be recruited from the patient population at Blythedale Children's Hospital for a six week trial.
Children will be assigned to one of two random groups: one weekly Balance Master sequence training group (in addition to their regularly scheduled therapy sessions) and a group that continue regularly scheduled therapy sessions alone.
Gait velocity will be measured by "Walk Across" Functional Assessment using Balance Master long force plate.
Study Type
Interventional
Enrollment (Actual)
71
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Valhalla, New York, United States, 10595
- Blythedale Children's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 21 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Ability to ambulate independently at least 25 feet with or without assistance device and/or orthoses.
- Receiving physical therapy services that include ambulation training.
Exclusion Criteria:
- Diagnosis of a progressive disorder.
- Inability to follow directions.
- Uncorrected vision impairment.
- Require additional physical assistance to ascend a ramp and over force plate.
- Refusal to participate.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Balance Master Training
Children receive one weekly Balance Master training session, in addition to their weekly physical therapy sessions.
During Balance Master training, children practice balance on a Balance Master device that simulates crossing a city street.
|
|
|
ACTIVE_COMPARATOR: Customary Care
Children received their customary scheduled physical therapy sessions, without Balance Master training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in gait velocity after intervention
Time Frame: measured at day 1 of intervention and end of week 6 of intervention
|
Measure gait velocity as participant walks across a force plate on the floor
|
measured at day 1 of intervention and end of week 6 of intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight
Time Frame: Day 1 of Intervention
|
Body weight on a digital scale
|
Day 1 of Intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2010
Primary Completion (ACTUAL)
January 1, 2016
Study Completion (ACTUAL)
January 1, 2016
Study Registration Dates
First Submitted
July 18, 2016
First Submitted That Met QC Criteria
July 20, 2016
First Posted (ESTIMATE)
July 22, 2016
Study Record Updates
Last Update Posted (ACTUAL)
May 18, 2018
Last Update Submitted That Met QC Criteria
May 17, 2018
Last Verified
May 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Balance_Master
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Palsy
-
Ankara City Hospital BilkentRecruitingCerebral Palsy (CP) | Cerebral Palsy, Spastic, Diplegic | Diplegic Cerebral Palsy With Spasticity | Transcranial Magnetic StimilationTurkey (Türkiye)
-
Lahore University of Biological and Applied SciencesRecruiting
-
Suleyman Demirel UniversityCompletedCerebral Palsy | Hemiplegic Cerebral Palsy | Spastic Diplegia Cerebral PalsyTurkey (Türkiye)
-
Holland Bloorview Kids Rehabilitation HospitalCanadian Institutes of Health Research (CIHR)RecruitingCerebral Palsy (CP) | Hemiplegic Cerebral PalsyCanada
-
Cairo UniversityCompletedCerebral Palsy (CP) | Unilateral Cerebral PalsyEgypt
-
University of California, San FranciscoNot yet recruitingCerebral Palsy | Cerebral Palsy (CP) | Infant | Cerebral Palsy InfantileUnited States
-
Lahore University of Biological and Applied SciencesNot yet recruitingSpastic Diplegia Cerebral PalsyPakistan
-
IRCCS Fondazione Stella MarisNot yet recruitingCerebral Palsy (CP) | EEG | Unilateral Cerebral Palsy | Action ObservationItaly
-
IRCCS Fondazione Stella MarisUniversity of Siena, ItalyRecruitingCerebral Palsy (CP) | Motor Imagery | CP (Cerebral Palsy) | Action ObservationItaly
-
University of LahoreCompletedCerebral Palsy (CP) | Spastic Diplegia Cerebral Palsy | Balance | Gross Motor FunctionsPakistan
Clinical Trials on Balance Master
-
Marmara UniversityCompleted
-
Marmara UniversityRecruiting
-
University of Sao Paulo General HospitalFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
Hyung Rock LeeCompletedHealthy | Concussion (Diagnosis) | Balance Assessment
-
Alanya Alaaddin Keykubat UniversityRecruitingPes Planus | Diaphragm Issues | Postural Control | Plantar PressureTurkey
-
Assiut UniversityNot yet recruitingError, Refractive
-
HealthWatch Ltd.CompletedAcute Coronary SyndromeIsrael
-
Shanghai 10th People's HospitalNot yet recruitingCataract | Artificial Intelligence (AI)
-
University of NebraskaRecruitingChronic Obstructive Pulmonary Disease | Asthma | DyspneaUnited States
-
Assiut UniversityNot yet recruitingCentral Corneal Thickness